Brainstorm Cell Therapeutics Inc (NAS:BCLI)
$ 2.35 0.12 (5.38%) Market Cap: 12.72 Mil Enterprise Value: 13.39 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q1 2023 Brainstorm Cell Therapeutics Inc Earnings Call Transcript

May 15, 2023 / 12:00PM GMT
Release Date Price: $41.4
Operator

Greetings, and welcome to the BrainStorm Cell Therapeutics first quarter 2023 earnings call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to introduce your host for today's call, Michael Wood of LifeSci Advisors. Mr. Wood, you may begin.

Michael Wood
LifeSci Advisors, LLC - IR

Well, good morning and thank you for joining us. Earlier today, BrainStorm issued a press release with its financial results for the first quarter of 2023, including a corporate update.

Before passing it over to the company management for prepared remarks, I want to remind listeners that this conference call will contain numerous statements, descriptions, forecasts, and projections regarding BrainStorm Cell Therapeutics and its potential future business operations and performance; statements regarding the market potential for the treatment of neurodegenerative diseases such as ALS, sufficiency of the company's existing capital resources for continuing operations in 2023 and beyond; the safety and clinical effectiveness of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot